Prognostic factors in metastatic disease.
Droz
J P
JP
Department of Medicine, Institut Gustave-Roussy, Villejuif, France.
Kramar
A
A
Rey
A
A
D014408:Biomarkers, Tumor / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008954:Models, Biological; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000556:secondary* / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors; D016879:Salvage Therapy; D013736:Testicular Neoplasms / Q000097:blood / Q000628:therapy*; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins